Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
4,410.00
3,692.00
3,275.00
2,709.00
2,167.00
1,446.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
4,410.00
3,692.00
3,275.00
2,709.00
2,167.00
1,446.00
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-2.00
-2.00
-1.00
-2.00
-5.00
Raw Materials Consumed
999.00
882.00
761.00
626.00
545.00
353.00
Power & Fuel Cost
68.00
62.00
59.00
57.00
47.00
38.00
Employee Cost
1,096.00
824.00
734.00
635.00
567.00
466.00
Operating Expenses
8.00
9.00
5.00
17.00
5.00
2.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
35.00
29.00
29.00
24.00
3.00
2.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
76.00
72.00
88.00
58.00
50.00
54.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
3,480.00
2,806.00
2,466.00
2,073.00
1,709.00
1,249.00
Operating Profit (PBDIT) excl Other Income
930.00
886.00
808.00
636.00
458.00
196.00
Other Income
98.00
78.00
74.00
49.00
38.00
31.00
Operating Profit (PBDIT)
1,028.00
965.00
883.00
685.00
496.00
228.00
Interest
90.00
74.00
83.00
86.00
86.00
72.00
Profit before Depriciation and Tax
938.00
890.00
799.00
599.00
410.00
155.00
Depreciation
222.00
193.00
172.00
149.00
129.00
123.00
Profit Before Taxation & Exceptional Items
716.00
697.00
627.00
449.00
280.00
32.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
715.00
647.00
627.00
449.00
280.00
32.00
Provision for Tax
160.00
165.00
149.00
123.00
84.00
3.00
Profit After Tax
554.00
481.00
478.00
326.00
196.00
28.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
2,248.00
1,764.00
1,283.00
952.00
768.00
737.00
Profit Available for appropriations
2,804.00
2,245.00
1,761.00
1,279.00
965.00
766.00
Appropriations
2,804.00
2,245.00
1,761.00
1,279.00
965.00
766.00
Equity Dividend (%)
25.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
20.71
17.92
17.80
12.58
7.78
1.15
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 19.44% vs 12.74% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 4.93% vs 9.56% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 21.11% vs -11.26% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 15.11% vs 0.68% in Mar 2025
Compare Profit and Loss Results of Global Health
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
4,410.00
4,138.00
272.00
6.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
4,410.00
4,138.00
272.00
6.57%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
18.00
-20.00
-111.11%
Raw Materials Consumed
999.00
920.00
79.00
8.59%
Power & Fuel Cost
68.00
89.00
-21.00
-23.60%
Employee Cost
1,096.00
760.00
336.00
44.21%
Operating Expenses
8.00
1,235.00
-1,227.00
-99.35%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
35.00
119.00
-84.00
-70.59%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
76.00
28.00
48.00
171.43%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3,480.00
3,365.00
115.00
3.42%
Operating Profit (PBDIT) excl Other Income
930.00
773.00
157.00
20.31%
Other Income
98.00
148.00
-50.00
-33.78%
Operating Profit (PBDIT)
1,028.00
921.00
107.00
11.62%
Interest
90.00
132.00
-42.00
-31.82%
Profit before Depriciation and Tax
938.00
788.00
150.00
19.04%
Depreciation
222.00
248.00
-26.00
-10.48%
Profit Before Taxation & Exceptional Items
716.00
540.00
176.00
32.59%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
715.00
471.00
244.00
51.80%
Provision for Tax
160.00
134.00
26.00
19.40%
Profit After Tax
554.00
355.00
199.00
56.06%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2,248.00
420.00
1,828.00
435.24%
Profit Available for appropriations
2,804.00
5,875.00
-3,071.00
-52.27%
Appropriations
2,804.00
5,875.00
-3,071.00
-52.27%
Equity Dividend (%)
25%
50%
-25.00
Earnings Per Share
20.71
107.98
-87.27
-80.82%
Profit And Loss - Net Sales
Net Sales 4,410.27 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.44% vs 12.74% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 930.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 4.93% vs 9.56% in Mar 2025
Profit And Loss - Interest
Interest 90.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 21.11% vs -11.26% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 554.07 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.11% vs 0.68% in Mar 2025






